Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that successfully result in decreasing its integration frequency at transcription start sites and CpG islands, thereby reducing the potential for insertional activation. The host bromo and extraterminal (BET) proteins Brd2, 3 and 4 interact with the MLV IN protein primarily through the BET protein ET domain. Using solution NMR, protein interaction studies, and next generation sequencing, we show that the C-terminal tail peptide region of MLV IN is important for the interaction with BET proteins and that disruption of this interaction through truncation mutations affects the global targeting profile of MLV vectors. The use of the unstructured tails of gammaretroviral INs to direct association with complexes at active promoters parallels that used by histones and RNA polymerase II. Viruses bearing MLV IN C-terminal truncations can provide new avenues to improve the safety profile of gammaretroviral vectors for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. NMR analysis of MLV IN: Brd3 ET interaction. A. MLV IN CTD sequence is displayed with the following color codes: green indicates backbone amide resonance chemical shifts that were the same for IN CTD in the presence or absence of Brd3 ET at pH 8.0; red indicates backbone amide resonances that are observed in the presence of Brd3 ET, but solvent exchange broadened in the absence of complex formation, and/or amide resonances that exhibit frequency shifts upon complex formation; blue indicates backbone amide resonance assignments that could not be determined at pH 8.0 either in the presence or absence of the Brd3 ET domain. Residues for which HN amide assignments could not be determined in either free or ET-bound CTD at pH 8.0 include R337, H338, T340, K341, N342, R346, W347, A367, S385, S386, Q396, as well as proline residues P345, P350, P358, P380, P384, P398 and P408 which lack amide protons. B. Cα backbone trace, along with key structural features, of an ensemble of 20 conformers of MLV IN CTD from amino acids 329–408 (PDB ID 2M9U) is shown in this panel with the same color codes as described in panel A. C. Ribbon representation of a single MLV IN CTD conformer is shown within a transparent view of a surface space fill model. Color code is the same as in panel A with key structural features and specific amino-acid residues that show significant CSPs and/or reduced amide proton exchange broadening marked in red. All images were generated using PyMol (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.) D. NMR spectrum of the IN CTD–Brd3 ET complex. Overlay of [15N−1H]-HSQC spectra of 15N-enriched IN CTD construct IN329–408 at pH 8.0, 300 mM NaCl either with (blue) or without (red) unlabeled Brd3ET. The stoichiometric ratio of IN329–408 (1 mM) and Brd3 ET (2 mM) was 1:2 at the concentrations indicated. Backbone amide resonances that are not affected by complex formation are labeled with sequence-specific assignments in black; assigned amide resonances that are not observable due to solvent-exchange broadening in the absence of ET, but become observable upon complex formation, as well as resonances exhibiting significant CSPs upon complex formation are labeled in magenta. All amide peak resonances not observable due to solvent-exchange broadening in the absence of ET, but become observable upon complex formation are marked with black circles; some of these could not be unambiguously assigned at pH 8.0. The curved green arrows indicate the CSPs due to complex formation of the amide resonances assigned to residues L399, L403, A407 and the side-chain indole NHϵ resonance of W390. Tryptophan W347 and W369 NHϵ side chain indole resonances with significant proton exchange rate reduction due to complex formation are also indicated. Peak resonances labeled in green are assigned to the non-cleavable affinity tag.](https://figures.cochat.ai/paper-figures/000fcaa623f843819c678f15da46cf1f/altering-murine-leukemia-virus-integration-through-disruption-of-the-integrase-figure-1.jpg)

![Figure 3. Mutating the consensus TP sequence inhibits interaction of MLV IN CTD with Brd3 ET. A. The 24-residue WT TP sequence is displayed on top and the mutant TP sequence is displayed on bottom. Underlined residues indicate amino-acid residues mutated to alanine. B. Comparison of [15N-1H]-HSQC spectra of the complex formed between 15N-enriched IN CTD (construct IN329–408) and unlabeled Brd3 ET in the presence of the WT TP (blue) and the free 15N-enriched IN CTD (construct IN329–408) spectra (red; same as Supplementary Figure S1B). The stoichiometric ratio of IN329–408 (200 μM) and Brd3 ET (200 μM) was 1:1 and the peptide was added at 3-fold molar excess (600 μM). Under these conditions, the WT TP disrupts the complex by binding to the ET domain, resulting in a spectrum for CTD that is different from that of the complex, but essentially identical to that of free IN CTD. C. Comparison of [15N-1H]-HSQC spectra of 15N-enriched IN CTD (construct IN329–408) and unlabeled Brd3 ET in the presence (red) or absence (blue) of the mutant TP. The stoichiometric ratio of IN329–408 (200 μM) and Brd3 ET (200 μM) was 1:1 and the mutant peptide was added at 3-fold excess (600 μM). The mutant TP does not disrupt the complex, and the spectrum is not changed when the peptide is added. In both panels, backbone amide resonances are labeled in black and peak resonances labeled in magenta are assigned to the non-cleavable affinity tag. Buffer conditions are as follows—buffer 1: 25 mM sodium phosphate pH 8.0, 300 mM NaCl, 50 mM potassium glutamate, 5 mM 2-mercaptoethanol. Buffer 2: 25 mM sodium phosphate pH 8.0, 360 mM NaCl, 60 mM potassium glutamate, 6 mM 2-mercaptoethanol.](https://figures.cochat.ai/paper-figures/8ff778ce1f8d454386125fde57026854/altering-murine-leukemia-virus-integration-through-disruption-of-the-integrase-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LEDGF/p75 interacts primarily with the lentiviral IN CCD dimer interface, BET proteins more simply engage a conserved linear sequence motif located at the C-terminus of γ-retroviral IN proteins114–116,121.”
From Structure and function of retroviral integrase (2022) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 2×
“However, despite the efficiency in gene delivery, insertional mutagenesis can result in clonal expansion of cells bearing specific integrants (2), associated with the preferential integration of murine leukemia virus (MLV) vectors upstream of transcription start sites (TSS) and CpG islands near promoter regions (3).”
BackgroundA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 1×
“Datasets used in the analysis: the inset box defines the data sets used in the analysis; FV fibroblast (21), HIV1 (22), MLV ((5) and this work), WT MLV IN1–408, MLV IN1–385 8N, MLV IN1–385 16H, MLV IN1–385 XN (in6215a (11), (Supplementary Table S4).”
MethodSelf-citationHIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655 · cited 1×
“nucleus, mediates the integration of the viral DNA into the host genome (6).”
BackgroundDynamic interactions between transposable elements and their hosts
Levin, H. L., & Moran, J. V. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3030 · Cited by 621
Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-10 · Cited by 532 · cited 1×
“Recent studies have identified NSD3, JMJD6, CHD4, GLTSCR1 and ATAD5 proteins as binding partners to the BET family members ET domain (48) and thus the ET domain functions to recruit specific effector proteins to regulate transcriptional activity.”
BackgroundShun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
Cited by
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
Wang, Z.-Q., Zhang, Z.-C., Wu, Y.-Y., Pi, Y.-N., Lou, S.-H., Liu, T.-B., Lou, G., & Yang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01647-6 · Cited by 216
Hindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
Self-citationGogol-Döring, A., Ammar, I., Gupta, S., Bunse, M., Miskey, C., Chen, W., Uckert, W., Schulz, T. F., Izsvák, Z., & Ivics, Z. (2016) · Molecular Therapy · doi:10.1038/mt.2016.11 · Cited by 160
Metadata
- Authors
- Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., Kvaratskhelia, M., Bushman, F. D., Montelione, G. T., & Roth, M. J.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- University of Pennsylvania (US)
- The Ohio State University (US)
- Brooklyn College (US)
- Corresponding author
- Montelione, Gaetano T.
- Roth, Monica J.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-12
- Volume
- 42
- Issue
- 9
- Pages
- 5917-5928
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4027182
- OpenAlex
- W2128712095
- Cited by
- 72
- References
- 51
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 6
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health (GM094597, AI062520)
- U.S. Public Health Service (PSCOOC-40-199)
- National Institute of General Medical Sciences (R01GM070837, GM070837, GM088808, R01GM088808, GM094597, U54GM094597, SC2GM088095)
- National Institute of Allergy and Infectious Diseases (AI062520, R21AI109522, AI052845, R01AI062520, R01AI052845, P30AI045008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- murine leukemia virus, integrase, BET proteins, BRD2, BRD3, BRD4, C-terminal tail, CpG islands, transcription start sites, gammaretroviral vectors, gene therapy safety, truncating mutations, vector targeting
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Binding Sites, Humans, Models, Molecular, Molecular Sequence Data, Leukemia Virus, Murine, Protein Binding, Transcription Factors, Viral Proteins, RNA-Binding Proteins, Virus Integration, Sequence Deletion, Sequence Analysis, DNA, CpG Islands, Integrases, Nuclear Magnetic Resonance, Biomolecular, Transcription Initiation Site, Protein Interaction Domains and Motifs, HEK293 Cells, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. https://app.cochat.ai/papers/10.1093/nar/gku175
- The paper
- Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., Kvaratskhelia, M., Bushman, F. D., Montelione, G. T., & Roth, M. J. (2014). Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. Nucleic Acids Research. https://doi.org/10.1093/nar/gku175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.